290 related articles for article (PubMed ID: 35246504)
21. ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM.
Zhang X; Zhang Z; Zhang Q; Zhang Q; Sun P; Xiang R; Ren G; Yang S
Cell Death Dis; 2018 Jan; 9(2):57. PubMed ID: 29352223
[TBL] [Abstract][Full Text] [Related]
22. The role of glycolysis and lactate in the induction of tumor-associated macrophages immunosuppressive phenotype.
Zhang Y; Zhang X; Meng Y; Xu X; Zuo D
Int Immunopharmacol; 2022 Sep; 110():108994. PubMed ID: 35777265
[TBL] [Abstract][Full Text] [Related]
23. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
[TBL] [Abstract][Full Text] [Related]
24. Revisiting the Warburg effect: historical dogma versus current understanding.
Vaupel P; Multhoff G
J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
[TBL] [Abstract][Full Text] [Related]
25. A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration.
Zou Q; Zhou E; Xu F; Zhang D; Yi W; Yao J
J Cell Biochem; 2018 Feb; 119(2):2189-2199. PubMed ID: 28857253
[TBL] [Abstract][Full Text] [Related]
26. Lactate secreted by esophageal cancer cells induces M2 macrophage polarization via the AKT/ERK pathway.
Zhang C; Cheng W; Yang T; Fang H; Zhang R
Thorac Cancer; 2023 Aug; 14(22):2139-2148. PubMed ID: 37345237
[TBL] [Abstract][Full Text] [Related]
27. A High Dose of Calcitriol Inhibits Glycolysis and M2 Macrophage Polarization in the Tumor Microenvironment by Repressing mTOR Activation: in vitro and Molecular Docking Studies.
Munir MT; Halim SA; Santos JM; Khan F; Khan A; Rahman MM; Hussain F; Al-Harrasi A; Gollahon LS; Rahman SM
Cell Physiol Biochem; 2023 Apr; 57(2):105-122. PubMed ID: 37052042
[TBL] [Abstract][Full Text] [Related]
28. ZEB1-regulated inflammatory phenotype in breast cancer cells.
Katsura A; Tamura Y; Hokari S; Harada M; Morikawa M; Sakurai T; Takahashi K; Mizutani A; Nishida J; Yokoyama Y; Morishita Y; Murakami T; Ehata S; Miyazono K; Koinuma D
Mol Oncol; 2017 Sep; 11(9):1241-1262. PubMed ID: 28618162
[TBL] [Abstract][Full Text] [Related]
29. CircRNA DNA methyltransferase 1 silence inhibits breast cancer development by regulating micoRNA-485-3p/zinc finger E-box binding homeobox 1 axis.
Xie C; Li J; Xu C; Xiong W; Yuan X
J Obstet Gynaecol Res; 2021 Mar; 47(3):1068-1081. PubMed ID: 33403756
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
31. A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours.
Fu R; Han CF; Ni T; Di L; Liu LJ; Lv WC; Bi YR; Jiang N; He Y; Li HM; Wang S; Xie H; Chen BA; Wang XS; Weiss SJ; Lu T; Guo QL; Wu ZQ
Nat Commun; 2019 Jul; 10(1):3210. PubMed ID: 31324807
[TBL] [Abstract][Full Text] [Related]
32. The Warburg Effect: Historical Dogma Versus Current Rationale.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2021; 1269():169-177. PubMed ID: 33966213
[TBL] [Abstract][Full Text] [Related]
33. TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer.
Ko YH; Domingo-Vidal M; Roche M; Lin Z; Whitaker-Menezes D; Seifert E; Capparelli C; Tuluc M; Birbe RC; Tassone P; Curry JM; Navarro-Sabaté À; Manzano A; Bartrons R; Caro J; Martinez-Outschoorn U
J Biol Chem; 2016 Dec; 291(51):26291-26303. PubMed ID: 27803158
[TBL] [Abstract][Full Text] [Related]
34. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
35. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
36. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
[TBL] [Abstract][Full Text] [Related]
37. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.
Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A
Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation.
Wang R; Xu F; Yang Z; Cao J; Hu L; She Y
BMC Urol; 2024 Mar; 24(1):59. PubMed ID: 38481182
[TBL] [Abstract][Full Text] [Related]
39. Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway.
Li J; Qu P; Zhou XZ; Ji YX; Yuan S; Liu SP; Zhang QG
Biomed Pharmacother; 2022 Jun; 150():113063. PubMed ID: 35658233
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic HBXIP enhances ZEB1 through Sp1 to accelerate breast cancer growth.
Jiang Y; Wang D; Ren H; Shi Y; Gao Y
Thorac Cancer; 2018 Dec; 9(12):1664-1670. PubMed ID: 30273966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
